Premium
A novel surgical technique for implanting a new electrostimulation system for treating female overactive bladder: a preliminary report
Author(s) -
Nissenkorn Israel,
De Jong Peter R.
Publication year - 2005
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2005.05498.x
Subject(s) - nocturia , medicine , overactive bladder , urinary incontinence , urge incontinence , urology , urinary urgency , implant , surgery , urinary system , alternative medicine , pathology
There are three interesting but diverse topics in this section. Authors from Tel‐Aviv and Capetown describe a novel surgical technique for implanting a new electrostimulation system for treating overactive bladder in the female. This is followed by a classification of symptomatic nocturia from Japan, which also looks at the distribution of nocturia, with special attention to duration of time in bed. Finally, there is an interesting paper on the association between congenital adrenal hyperplasia and LUTS. OBJECTIVE To assess the results of peripheral electrostimulation of pelvic floor muscles in patients with overactive bladder (OAB) symptoms, and to describe a novel surgical technique for inserting a specially designed implantable electrostimulator which can deliver different forms of muscle stimulation through a para‐urethral electrode. PATIENTS AND METHODS The study included seven women with OAB (mean age 59 years) who had frequency (including nocturia), urgency and urge incontinence for ≥ 1 year, and in whom conventional treatment failed. The antepubic technique was used to implant the electrostimulator and a para‐urethral electrode. The patients’ urinary symptoms and quality of life (King's College Hospital incontinence questionnaire) were compared before and after surgery, and possible complications monitored. RESULTS The mean (range) follow‐up was 14.5 (13–17) months in six and 10 months in the seventh patient (stimulator removed because of infection). The mean (range) frequency of 15 (13–23) voids/24 h before surgery decreased to 9 voids/24 h (i.e. by 40%) afterward. All patients had leakage episodes because of urgency (4–15 times/day) before surgery, which ceased in five afterward; these patients used no further pads. In the remaining two patients urgency incontinence continued after surgery, but with significantly fewer leakage episodes, from 15 and 12 per day before to 6.7 and 4 afterward, respectively. The mean degree of urgency (graded 0–3) decreased from 2 to 1.4 after surgery, and quality of life improved significantly. Urodynamic studies showed a greater mean maximum detrusor capacity, from 135 mL before to 189 mL after implanting the stimulator. CONCLUSIONS The good results (over a follow‐up of 1 year) in patients with OAB symptoms treated by the present electrostimulator should encourage further clinical studies in such patients. A trial to evaluate the efficacy of pelvic floor muscle electrostimulation in a broad spectrum of diseases of the lower urinary tract causing symptoms similar to OAB has been started.